CTO MESSAGE
ABOUT COGNOHEAL
The clinical manifestations resulting from AD include memory and cognitive impairment, anxiety, confusion, language difficulties, and mood swings. Current treatments including acetylcholine esterase inhibitors or NMDA receptors antagonists are somehow symptomatic, showing side-effects and may not heal the disease. Despite extensive considerations, an efficient therapeutic has remained elusive thus far.
Have you ever tried CBD oil? If so, what was your experience like?
I have tried https://premiumjane.com/cbd-oils/ , and I found it to be very effective for managing my anxiety. I felt calmer and more relaxed after taking it, and it helped me to sleep better at night. I would definitely recommend it to anyone who is looking for a natural way to reduce anxiety or improve their sleep.
What do you think about CBD oil becoming legal in Maryland?
I'm so happy that https://purekana.com/blogs/news/cbd-oil-in-maryland/ is becoming legal in Maryland! I've been using it for a while now and it's amazing how well it works. I used to have a lot of pain in my back from an old injury, but CBD oil has really helped to get rid of that pain.
Have you ever used medical marijuana for a valid excuse?
Yes, I've excuses to get a medical marijuana card as a valid excuse before. I have a friend who is a doctor and he set me up with a legal medical marijuana card.
CTO MESSAGE
ABOUT COGNOHEAL
The clinical manifestations resulting from AD include memory and cognitive impairment, anxiety, confusion, language difficulties, and mood swings. Current treatments including acetylcholine esterase inhibitors or NMDA receptors antagonists are somehow symptomatic, showing side-effects and may not heal the disease. Despite extensive considerations, an efficient therapeutic has remained elusive thus far.
ALZHEIMER’S DISEASE
DIAGNOSIS KIT
We have previously shown the pathogenic pT231-tau, which is an early driver of tauopathy and neurodegeneration, is having a prion nature and spreads in brain areas as well as CSF and even into the blood. As mentioned earlier, we have now generated a fully human monoclonal antibody (scFv domain) against the pathogenic conformer and have shown that antibody specifically recognizes the pathogenic p-tau species.
ALZHEIMER’S DISEASE
DIAGNOSIS KIT
We have previously shown the pathogenic pT231-tau, which is an early driver of tauopathy and neurodegeneration, is having a prion nature and spreads in brain areas as well as CSF and even into the blood. As mentioned earlier, we have now generated a fully human monoclonal antibody (scFv domain) against the pathogenic conformer and have shown that antibody specifically recognizes the pathogenic p-tau species.
SPECT TAU IMAGING
WThere is a gradual increase in the pT231-tau epitope confirmed by immunostaining of human AD postmortem brains. Moreover, we performed immunoblotting analysis on human AD and healthy brain extracts using our antibody and compared the results with anti cis pT231-tau mouse monoclonal antibody.
Learn MoreSPECT TAU IMAGING
WThere is a gradual increase in the pT231-tau epitope confirmed by immunostaining of human AD postmortem brains. Moreover, we performed immunoblotting analysis on human AD and healthy brain extracts using our antibody and compared the results with anti cis pT231-tau mouse monoclonal antibody.
Learn MoreOUR PARTNERS
OUR PARTNERS